IC
ICICI Prudential Quality Fund Direct Growth
Latest NAV
+2.36% 1Y
Sign In to Add to Portfolio
Benchmark: Nifty 200 Quality 30 TRI
Expense ratio
1.34%
AUM
₹2,144 Cr
Min SIP
₹100
Min lump sum
₹5,000
1Y
+2.36%
3Y (ann.)
+0.00%
5Y (ann.)
+0.00%
Launched
May 2025
Where the NAV sits & how risky it is
₹10.42
52-week range
at 63%
₹10.42
Low 30 Mar 2026₹9.38
High 03 Aug 2026₹11.02
Risk level
Very High
Low
Very high
NAV history
26 May 2025
Since inception
05 Oct 2026
Returns by period
1W
-2.44%
1M
-4.94%
3M
-0.57%
6M
+9.37%
1Y
+2.36%
3Y
+0.00%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 93.54%
Cash & other 9.19%
Sector split
Country split
Top 5 hold 21.6%
Top 10 hold 36.5%
66 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | ICICI Bank
INE090A01021 |
Financial Services Banks - Regional |
India |
6.63%
|
-0.64% |
| 2 | Bharat Electronics
INE263A01024 |
Industrials Aerospace & Defense |
India |
4.04%
|
+2.48% |
| 3 | Infosys
INE009A01021 |
Technology Information Technology Services |
India |
3.78%
|
-27.66% |
| 4 | Divis Laboratories
INE361B01024 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.58%
|
+5.01% |
| 5 | HDFC Bank
INE040A01034 |
Financial Services Banks - Regional |
India |
3.57%
|
-20.81% |
| 6 | Sun Pharmaceutical
INE044A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.45%
|
+5.35% |
| 7 | AstraZeneca Pharma
INE203A01020 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.22%
|
-6.71% |
| 8 | Hindustan Unilever
INE030A01027 |
Consumer Defensive Household & Personal Products |
India |
2.89%
|
-5.01% |
| 9 | Cholamandalam Investment
INE121A01024 |
Financial Services Credit Services |
India |
2.83%
|
-2.78% |
| 10 | Mahindra & Mahindra
INE101A01026 |
Consumer Cyclical Auto Manufacturers |
India |
2.50%
|
-15.50% |
About this scheme
To generate long-term capital appreciation by investing in Equity & Equity related instruments of companies identified based on the Quality Factor.
Fund manager(s): Masoomi Jhurmarvala
Exit load: Exit load of 1% if redeemed within 1 month.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
23 May 2025
Lump-sum min
₹5,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 119.2 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 31.0 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 28.2 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 28.2 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 26.9 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 26.8 pts ahead of this fund